The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

Midan included 10 trends with implications for the meat industry while identifying two macro-factors that are expected to ...

The 'game changing' weekly injections have helped thousands of people who need to lose weight and improve their health. But ...

Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...